Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (521-530 of 777) with videos related to

Pageof 78
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2021
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varicesRafael Paternostro, Jeannette Becker, Benedikt Silvester Hofer, et al.
World Journal of Hepatology|March 23, 2016
Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse modelFlorian P Reiter, Ralf Wimmer, Lena Wottke, et al.
Scientific Reports|April 20, 2018
Deviations of the immune cell landscape between healthy liver and hepatocellular carcinomaNataliya Rohr-Udilova, Florian Klinglmüller, Rolf Schulte-Hermann, et al.
Journal of Viral Hepatitis|March 11, 2022
The 'Viennese epidemic' of acute HCV in the era of direct-acting antiviralsDavid Chromy, David J M Bauer, Benedikt Simbrunner, et al.
Surgical Endoscopy|November 8, 2013
Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applicationsWerner Dolak, Florian Schreiber, Hubert Schwaighofer, et al.
Gastroenterology|February 14, 2006
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout micePeter Fickert, Martin Wagner, Hanns-Ulrich Marschall, et al.
Cell Death & Disease|October 27, 2017
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosisKatharina Staufer, Mirko Dengler, Heidemarie Huber, et al.
Hepatology Communications|July 5, 2021
COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related MortalityLukas Hartl, Georg Semmler, Benedikt Silvester Hofer, et al.
JHEP Reports : Innovation in Hepatology|March 6, 2023
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver diseaseLorenz Balcar, Julia Krawanja, Bernhard Scheiner, et al.
Annals of Hepatology|June 12, 2026
Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation eventLorenz Balcars, Adrian Wunderbaldinger, Lucie Simonis, et al.
Pageof 78

Showing results (521-530 of 777) with videos related to

Sort By:
Pageof 78
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2021
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varicesRafael Paternostro, Jeannette Becker, Benedikt Silvester Hofer, et al.
World Journal of Hepatology|March 23, 2016
Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse modelFlorian P Reiter, Ralf Wimmer, Lena Wottke, et al.
Scientific Reports|April 20, 2018
Deviations of the immune cell landscape between healthy liver and hepatocellular carcinomaNataliya Rohr-Udilova, Florian Klinglmüller, Rolf Schulte-Hermann, et al.
Journal of Viral Hepatitis|March 11, 2022
The 'Viennese epidemic' of acute HCV in the era of direct-acting antiviralsDavid Chromy, David J M Bauer, Benedikt Simbrunner, et al.
Surgical Endoscopy|November 8, 2013
Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applicationsWerner Dolak, Florian Schreiber, Hubert Schwaighofer, et al.
Gastroenterology|February 14, 2006
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout micePeter Fickert, Martin Wagner, Hanns-Ulrich Marschall, et al.
Cell Death & Disease|October 27, 2017
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosisKatharina Staufer, Mirko Dengler, Heidemarie Huber, et al.
Hepatology Communications|July 5, 2021
COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related MortalityLukas Hartl, Georg Semmler, Benedikt Silvester Hofer, et al.
JHEP Reports : Innovation in Hepatology|March 6, 2023
Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver diseaseLorenz Balcar, Julia Krawanja, Bernhard Scheiner, et al.
Annals of Hepatology|June 12, 2026
Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation eventLorenz Balcars, Adrian Wunderbaldinger, Lucie Simonis, et al.
Pageof 78